Sabitlenmiş Tweet
PUNIT
983 posts

PUNIT
@punitjn
Lead Hematologist & BMT Physician @ Apollo Hosp, Navi Mumbai, & HematCare - Speciality Hematology Clinic @ Powai “ Stay optimistic, Stay focused & Believe “
Mumbai Katılım Temmuz 2009
953 Takip Edilen869 Takipçiler
PUNIT retweetledi

In continued observance of Bleeding Disorders Awareness Month, we're highlighting an important article from Blood Advances on the treatment of von Willebrand Disease. ashpublications.org/bloodadvances/…
#vonwillebranddisease #BDAM #bloodadvances
English
PUNIT retweetledi

~10% of mantle cell lymphoma (MCL) cases lack CD38 expression — and this matters.
CD38-negative MCL is linked to higher rates of TP53 alterations, distinct mutational profiles (NOTCH, CD79B, CXCR4), and features overlapping with leukemic non-nodal MCL.
authors.elsevier.com/a/1mo3sAfIPxMv…

English
PUNIT retweetledi

Post-transplantation cyclophosphamide dosed by total body weight leads to delay of platelet engraftment in obese patients @ASTCT_Journal
astctjournal.org/article/S2666-…
English
PUNIT retweetledi

Successful Treatment of Aplastic Anemia With Eltrombopag During Pregnancy: A Short Report
onlinelibrary.wiley.com/doi/epdf/10.10…

English
PUNIT retweetledi

This real-world study finds that combining #CART therapy with autologous transplantation improves complete remission and long-term survival in relapsed or refractory diffuse large B-cell lymphoma compared with CAR-T alone. Read more: ow.ly/W8br50YuN8T

English
PUNIT retweetledi

This review examines the current state of #CART therapy in pediatric B-ALL, assess current and emerging integration of CAR T-cells into treatment algorithms and discuss emerging strategies to overcome existing challenges. Read: astctjournal.org/article/S2666-…

English
PUNIT retweetledi
PUNIT retweetledi

Current treatment algorithm: diffuse large B cell lymphoma | Blood Cancer Journal share.google/7HdCdx4MKaXBq6…
English
PUNIT retweetledi

🚨 New head-to-head RCT in @NEJM: apixaban vs rivaroxaban 🥊
🏆 Apixaban emerges as the safe winner, with half the risk of bleeding complications
💡 For patients at high risk of GI bleeding, apixaban may be preferrable to rivaroxaban
nejm.org/doi/full/10.10…

English
PUNIT retweetledi

Chronic graft-versus-host disease (cGVHD) remains a major cause of long-term morbidity after allogeneic stem cell transplantation. A new European position statement highlights current challenges and priorities for prevention, diagnosis, and treatment.
nature.com/articles/s4140…
English
PUNIT retweetledi

Respect from colleagues, who are working towards the same objective, always drives an athlete forward.
There was no shortage of that for #LakshyaSen after his exploits at #AllEnglandOpen2026
Watch!
(📽️: IG/Mithun Manjunath)
English

Take a bow , Lakshya Sen ! Lost in the finals of the All England Badminton open ! You remain our champion ! Keep going !!
Abhinav A. Bindra OLY@Abhinav_Bindra
Not every inspiring sporting story ends with a trophy. Over the last few days, Lakshya Sen has shown India what courage, resilience and belief truly look like. His run to another All England final, through extraordinary wins and immense physical pain, has been about far more than a result. He has reminded young India that greatness lies not only in winning, but in the honesty of effort, the dignity of the fight and the strength to keep believing. I am Proud of you, @lakshya_sen . Very, very proud.
English
PUNIT retweetledi
PUNIT retweetledi

PD-1 blockade given before ASCT is associated with superior post-ASCT outcomes in R/R cHL. Read in Blood: ow.ly/a2M650YpLj4

English
PUNIT retweetledi

PARADIGM Trial (ND #AML) 🧬
• Aza-Ven vs intensive chemo in fit adults
• EFS: 14.6 vs 6.15 months
• CR rate: 81% vs 55%
• Bridge to SCT: 61% vs 40%
• 0% 60-day mortality with Aza-Ven
➡️ Aza-Ven shows better efficacy, safety, and QoL.


English
PUNIT retweetledi

🚨BREAKING: If you've used ChatGPT for writing or brainstorming in the last 6 months, your creative ability may already be permanently damaged.
A controlled experiment just proved the effect doesn't reverse when you stop using it.
3,302 creative ideas. 61 people. 30 days of tracking.
Researchers split students into two groups. Half used ChatGPT for creative tasks. Half worked alone. For five days, the ChatGPT group outperformed on every metric. Higher scores. More ideas. Better output. AI was making them better.
Then day 7. ChatGPT removed. Every creativity gain vanished overnight. Crashed to baseline. Zero lasting improvement.
But that's not the bad part.
ChatGPT users' ideas became increasingly identical to each other over time. Same content. Same structure. Same phrasing. The researchers called it homogenization. Everyone using ChatGPT started producing the same ideas wearing different clothes.
When ChatGPT was removed, the creativity boost disappeared -- but the homogenization stayed. 30 days later, same result. Their creative range had been permanently compressed.
Five days of use. Permanent damage 30 days later.
A separate trial confirmed it. 120 students. 45-day surprise test. ChatGPT users scored 57.5%. Traditional learners scored 68.5%. AI reduces cognitive effort. Less effort means weaker encoding. Weaker encoding means less creative raw material.
You're not renting a productivity boost. You're financing it with your originality.
The interest rate is permanent.

English
PUNIT retweetledi

Dasatinib, ponatinib, and nilotinib damage ECs in different ways, all of which can contribute to arterial #thrombosis. Read in Blood VTH: ow.ly/acl550YpKI0

English
PUNIT retweetledi
PUNIT retweetledi

We grew up so fast.. 😭 twitter.com/SelflessCricke…
English
PUNIT retweetledi







